Foot Injections for Pain: Cortisone vs. PRP vs. Fat Pad Restoration

Injection Type	What’s Injected	Mechanism	Duration	Evidence Level	Best Candidate
Cortisone (corticosteroid)	Triamcinolone or methylprednisolone	Potent anti-inflammatory; reduces synovitis and bursitis	4–12 weeks per injection	Strong for plantar fasciitis; moderate for fat pad syndrome	Acute plantar fasciitis flare; heel bursitis; short-term relief before other treatment
PRP (platelet-rich plasma)	Patient’s own concentrated platelets (3–5x blood levels)	Growth factor delivery (PDGF, TGF-β, IGF); promotes tissue repair and angiogenesis	6–18 months per injection	Moderate for plantar fasciitis (superior to cortisone at 6–12 months)	Chronic plantar fasciitis (>6 months); failed cortisone; active patients wanting durable result
Hyaluronic acid (HA) viscosupplementation	Cross-linked hyaluronic acid gel	Joint lubrication; anti-inflammatory; cartilage protection	3–6 months	Moderate for 1st MTP joint and ankle OA; less data for heel	Big toe joint OA (hallux limitus); ankle OA; failed cortisone
Autologous fat transfer	Patient’s own fat (lipoaspirate from abdomen/thigh)	Mechanically restores fat pad volume; acts as natural cushion	Potentially permanent (fat cells survive if vascularity established)	Emerging; positive case series for heel fat pad atrophy	Documented fat pad atrophy on ultrasound; failed orthotics and padding; chronic heel pain from cushion loss
Filler (hyaluronic acid dermal filler — off-label)	High-viscosity HA filler (Restylane Lyft, Radiesse)	Volume restoration; mechanical cushioning	6–18 months (HA); 12–24 months (Radiesse)	Low — case series and small studies; off-label use	Fat pad atrophy in patients unwilling to undergo fat transfer; aesthetic medicine setting
Dry needling / tendon fenestration	No injectate — needling only	Breaks adhesions; induces healing response; stimulates platelet aggregation	Variable; often used with PRP	Moderate (combined with PRP > PRP alone for tendinopathy)	Chronic plantar fasciitis; insertional Achilles tendinopathy; used as adjunct

Condition	First-Line Injection	Second-Line If Failed	Notes
Acute plantar fasciitis (<3 months)	Cortisone (ultrasound-guided)	PRP if recurs within 3 months	Cortisone has highest evidence for acute reduction; risk of fat pad atrophy with >3 injections
Chronic plantar fasciitis (>6 months)	PRP (ultrasound-guided)	ESWT (shockwave) if PRP insufficient	Multiple RCTs show PRP superior to cortisone at 6–12 months; single injection often sufficient
Heel fat pad syndrome / atrophy	Autologous fat transfer or HA filler (volume restoration)	Custom heel cup + accommodation orthotics ongoing	Cortisone contraindicated — accelerates fat pad atrophy; address the cushion loss, not inflammation
Hallux limitus / 1st MTP OA	Cortisone (intra-articular)	HA viscosupplementation; PRP	Limit cortisone to 2–3 per year to avoid cartilage degradation
Ankle OA flare	Cortisone (intra-articular)	HA; PRP; surgical referral	Ultrasound guidance critical for ankle injection accuracy
Morton’s neuroma	Cortisone + 4% alcohol sclerosing series	Surgical neurectomy if 4–6 injections fail	Sclerosing series (4–6 weekly injections) achieves 60–80% resolution; avoids surgery

Foot Injections for Pain: Understanding Your Options

Foot injections for pain — whether cortisone, PRP, or hyaluronic acid — are among the most common non-surgical interventions in podiatric practice. The right injection depends entirely on what’s being treated: cortisone is the fastest-acting anti-inflammatory but can damage the heel fat pad with repeated use; PRP is better for chronic tendon problems where tissue repair is needed rather than inflammation suppression; and autologous fat or filler are the only options that actually restore lost cushioning in fat pad atrophy. Choosing the wrong injection for the wrong condition produces poor results — which is why many patients report that “cortisone didn’t help” for a problem that was never inflammatory in the first place.

Cortisone Injections: The Right Use and the Key Limitation

Cortisone (corticosteroid) injections are the most commonly administered foot injection and produce excellent short-term relief for true inflammatory conditions: acute plantar fasciitis, bursitis, synovitis, and joint inflammation in OA flares. A single ultrasound-guided cortisone injection into an acutely inflamed plantar fascia insertion produces relief in 70–80% of patients within 1–2 weeks. The limitation: the anti-inflammatory effect lasts 4–12 weeks and does not address the underlying mechanical cause. More critically, repeated cortisone injections into the heel fat pad are associated with fat pad atrophy — the padding that protects the calcaneus degrades, creating heel pain that is worse than the original condition and much harder to treat. The consensus guideline is a maximum of 2–3 cortisone injections per site per year, with a preference for ultrasound guidance to precisely target the fascia rather than the fat pad.

PRP: Better Than Cortisone for Chronic Conditions

Platelet-rich plasma (PRP) is prepared by centrifuging the patient’s own blood to concentrate platelets 3–5 times above baseline. The resulting plasma is rich in growth factors (PDGF, TGF-β, VEGF, IGF-1) that promote tissue repair, tendon healing, and anti-inflammatory signaling. For chronic plantar fasciitis (>6 months duration), multiple randomized controlled trials demonstrate that a single PRP injection is superior to cortisone at 6 and 12 months — cortisone produces faster early relief (weeks 4–6) but PRP produces more durable improvement beyond month 3. PRP is the preferred injection for chronic tendinopathies (plantar fascia, Achilles insertional tendinopathy) where the tissue needs repair rather than inflammation suppression. The procedure requires a blood draw and a 10–15 minute centrifuge preparation time; the injection is similar to cortisone. Side effects include a 24–72 hour post-injection flare (pain increase as the growth factors initiate the repair response) that resolves without intervention.

Fat Pad Atrophy: When Cushioning Is the Problem

Heel fat pad syndrome — thinning or displacement of the calcaneal fat pad — produces a distinct type of heel pain: diffuse, centrally located pain with direct pressure on the heel (rather than the medial fascia origin pain of plantar fasciitis), worse on hard floors in bare feet, better with cushioned shoes. It is most common in elderly patients (natural fat pad atrophy with aging), runners with high mileage, and patients who have received multiple cortisone injections. For fat pad atrophy, cortisone is contraindicated (it accelerates the problem). Custom accommodative orthotics with deep heel cups and cushioning padding are the mainstay of conservative management. When padding provides insufficient relief, autologous fat transfer (injecting the patient’s own liposuctioned fat into the heel pad) or off-label dermal filler injection are emerging options that mechanically restore the lost cushion.

At Balance Foot & Ankle, Dr. Tom Biernacki and Dr. Carl Jay provide ultrasound-guided cortisone, PRP, and HA injections for foot and ankle pain at both the Howell and Bloomfield Hills offices. Call (810) 206-1402.

For a complete clinical overview: Heel Pain Causes & Treatment Guide — every cause of foot and heel pain diagnosed